Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#121 / 200 Total
UTHR - United Therapeutics Corp - Stock Price Chart
TickerUTHR [NASD]
CompanyUnited Therapeutics Corp
CountryUSA
IndustryBiotechnology
Market Cap11.32BEPS (ttm)19.84
P/E12.86EPS this Y22.33%
Forward P/E10.11EPS next Y4.17%
PEG1.33EPS past 5Y8.15%
P/S4.86EPS next 5Y9.70%
P/B2.01EPS Q/Q63.02%
Dividend-Sales Q/Q25.07%
Insider Own7.84%Inst Own101.13%
Insider Trans-11.23%Inst Trans1.04%
Short Float10.56%EarningsMay 01/b
Analyst Recom1.59Target Price292.52
Avg Volume477.18K52W Range204.44 - 261.54
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROTHBLATT MARTINE ACHAIRPERSON & CEOApr 30 '24Option Exercise129.493,600466,1643,730May 01 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOApr 30 '24Sale235.353,600847,277130May 01 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOApr 29 '24Option Exercise129.493,600466,1643,730May 01 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOApr 29 '24Sale238.643,600859,088130May 01 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOApr 26 '24Option Exercise129.493,600466,1643,730Apr 29 04:30 PM
IMTX - Immatics N.V - Stock Price Chart
TickerIMTX [NASD]
CompanyImmatics N.V
CountryGermany
IndustryBiotechnology
Market Cap1.11BEPS (ttm)-1.30
P/E-EPS this Y-7.20%
Forward P/E-EPS next Y-6.71%
PEG-EPS past 5Y-17.16%
P/S19.06EPS next 5Y13.15%
P/B3.68EPS Q/Q-44.94%
Dividend-Sales Q/Q-6.55%
Insider Own30.42%Inst Own44.26%
Insider Trans0.00%Inst Trans2.33%
Short Float12.52%EarningsMar 21/b
Analyst Recom1.00Target Price18.08
Avg Volume423.80K52W Range6.91 - 13.16
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. The company was founded on March 10, 2020, and is headquartered in Tuebingen, Germany.
NRIX - Nurix Therapeutics Inc - Stock Price Chart
TickerNRIX [NASD, RUT]
CompanyNurix Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap775.91MEPS (ttm)-2.65
P/E-EPS this Y-11.80%
Forward P/E-EPS next Y-8.82%
PEG-EPS past 5Y-59.00%
P/S9.59EPS next 5Y-
P/B3.81EPS Q/Q-0.31%
Dividend-Sales Q/Q30.74%
Insider Own7.90%Inst Own69.71%
Insider Trans-0.76%Inst Trans-4.59%
Short Float12.88%EarningsApr 10/b
Analyst Recom1.36Target Price25.09
Avg Volume1.03M52W Range4.22 - 18.12
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rape, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hansen GwennChief Scientific OfficerApr 30 '24Option Exercise0.005,206041,608Apr 30 06:33 PM
Ring ChristineChief Legal OfficerApr 30 '24Option Exercise0.003,924021,351Apr 30 06:33 PM
van Houte HansChief Financial OfficerApr 30 '24Option Exercise0.004,886073,219Apr 30 06:33 PM
Hansen GwennChief Scientific OfficerApr 30 '24Sale12.042,00724,16939,601Apr 30 06:33 PM
Ring ChristineChief Legal OfficerApr 30 '24Sale12.041,51318,22019,838Apr 30 06:33 PM
AXTA - Axalta Coating Systems Ltd - Stock Price Chart
TickerAXTA [NYSE]
CompanyAxalta Coating Systems Ltd
CountryUSA
IndustrySpecialty Chemicals
Market Cap7.55BEPS (ttm)1.21
P/E28.38EPS this Y21.27%
Forward P/E15.73EPS next Y14.23%
PEG1.81EPS past 5Y7.16%
P/S1.46EPS next 5Y15.70%
P/B4.36EPS Q/Q68.14%
Dividend0.24%Sales Q/Q4.90%
Insider Own0.38%Inst Own98.42%
Insider Trans-4.65%Inst Trans0.07%
Short Float3.04%EarningsMay 01/b
Analyst Recom1.80Target Price37.37
Avg Volume2.10M52W Range25.03 - 34.53
Axalta Coating Systems Ltd. engages in the manufacture, marketing and distribution of coatings systems. It operates through the Performance Coatings and Mobility Coatings segments. The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. The Mobility Coatings segment offers coatings technologies to original equipment manufacturers of light and commercial vehicles. The company was founded in 1866 and is headquartered in Philadelphia, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Awada HadiSVP, Glbl Mobility CoatingsDec 04 '23Sale31.9910,500335,89514,656Dec 05 05:14 PM
BERUBE BRIAN ASVP and General CounselNov 17 '23Sale31.197,500233,92544,408Nov 17 06:55 PM
Massey AnthonyVP, Global Controller, PAONov 14 '23Option Exercise9.6514,601140,84637,335Nov 15 05:50 PM
Massey AnthonyVP, Global Controller, PAONov 14 '23Sale30.8817,915553,21519,420Nov 15 05:50 PM
MCLAUGHLIN ROBERT MDirectorNov 09 '23Sale29.775,000148,85092,649Nov 13 04:39 PM
SPRO - Spero Therapeutics Inc - Stock Price Chart
TickerSPRO [NASD]
CompanySpero Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap83.26MEPS (ttm)0.42
P/E3.64EPS this Y-298.26%
Forward P/E-EPS next Y8.50%
PEG0.10EPS past 5Y-
P/S0.86EPS next 5Y36.90%
P/B0.77EPS Q/Q75.41%
Dividend-Sales Q/Q54.95%
Insider Own27.35%Inst Own21.26%
Insider Trans-1.53%Inst Trans-5.12%
Short Float1.31%EarningsMar 13/a
Analyst Recom1.50Target Price7.50
Avg Volume320.96K52W Range0.99 - 2.00
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shukla SathCEO and PresidentFeb 05 '24Sale1.4545,09365,3851,176,007Feb 05 08:40 PM
Mahadevia AnkitDirectorFeb 02 '24Sale1.3763,79587,399744,997Feb 05 08:50 PM
JOSEPH TAMARA LChief Legal OfficerFeb 02 '24Sale1.3730,90642,341531,615Feb 05 08:48 PM
Shukla SathCEO and PresidentFeb 02 '24Sale1.3730,90142,3341,221,100Feb 05 08:40 PM
Keutzer TimothyChief Operating OfficerFeb 02 '24Sale1.3630,97142,121534,050Feb 05 08:53 PM
FLXS - Flexsteel Industries, Inc. - Stock Price Chart
TickerFLXS [NASD]
CompanyFlexsteel Industries, Inc.
CountryUSA
IndustryFurnishings, Fixtures & Appliances
Market Cap184.63MEPS (ttm)2.96
P/E12.13EPS this Y140.23%
Forward P/E11.75EPS next Y45.93%
PEG-EPS past 5Y4.24%
P/S0.45EPS next 5Y-
P/B1.29EPS Q/Q19.74%
Dividend1.67%Sales Q/Q8.25%
Insider Own30.73%Inst Own36.86%
Insider Trans0.00%Inst Trans26.18%
Short Float0.97%EarningsApr 29/a
Analyst Recom1.00Target Price50.00
Avg Volume28.09K52W Range15.67 - 41.64
Flexsteel Industries, Inc. engages in the manufacture, import, and marketing of residential and commercial upholstered, and wood furniture products. Its products include sofas, loveseats, chairs, reclining and rocker-reclining chairs, swivel rockers, sofa beds, convertible bedding units, occasional tables, desks, dining tables and chairs, and bedroom furniture. The company was founded in 1893 and is headquartered in Dubuque, IA.
RXST - RxSight Inc - Stock Price Chart
TickerRXST [NASD, RUT]
CompanyRxSight Inc
CountryUSA
IndustryMedical Devices
Market Cap2.11BEPS (ttm)-1.42
P/E-EPS this Y30.27%
Forward P/E-EPS next Y28.11%
PEG-EPS past 5Y-
P/S23.66EPS next 5Y19.00%
P/B12.78EPS Q/Q54.24%
Dividend-Sales Q/Q77.65%
Insider Own15.95%Inst Own79.07%
Insider Trans-19.98%Inst Trans-1.02%
Short Float4.70%EarningsMay 06/a
Analyst Recom1.00Target Price62.62
Avg Volume400.72K52W Range17.59 - 58.21
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thunen Shelley BChief Financial OfficerApr 01 '24Sale49.9020,000997,9468,402Apr 02 04:18 PM
Thunen Shelley BChief Financial OfficerMar 01 '24Option Exercise15.6010,000155,98323,691Mar 05 04:05 PM
Thunen Shelley BChief Financial OfficerMar 01 '24Sale56.3710,000563,72613,691Mar 05 04:05 PM
Goldshleger IlyaChief Operating OfficerFeb 16 '24Option Exercise23.0410,000230,40036,475Feb 16 05:00 PM
Goldshleger IlyaChief Operating OfficerFeb 16 '24Sale55.5010,000555,00026,475Feb 16 05:00 PM
VIK - Viking Holdings Ltd. - Stock Price Chart
TickerVIK [NYSE]
CompanyViking Holdings Ltd.
CountryBermuda
IndustryTravel Services
Market Cap226.03MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume-52W Range- - -
Viking Holdings Ltd. provides destination-focused itineraries for curious travelers. The firm's journeys including a shore excursion in every port and an onboard and onshore enrichment program that provides deep immersion in the destination through performances of music and art, cooking demonstrations, informative port talks and carefully selected guest lecturers. It provides travel experiences through river vessels, ocean ships, expedition ships and time chartered river ship. The company was founded by Torstein Hagen in 1997 and is headquartered in Hamilton, Bermuda.
AUTL - Autolus Therapeutics plc ADR - Stock Price Chart
TickerAUTL [NASD]
CompanyAutolus Therapeutics plc ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap696.40MEPS (ttm)-1.20
P/E-EPS this Y42.57%
Forward P/E-EPS next Y17.43%
PEG-EPS past 5Y3.32%
P/S409.65EPS next 5Y-
P/B6.25EPS Q/Q-92.78%
Dividend-Sales Q/Q-100.00%
Insider Own9.38%Inst Own61.85%
Insider Trans0.00%Inst Trans-1.84%
Short Float2.58%EarningsMay 14/b
Analyst Recom1.36Target Price10.69
Avg Volume1.73M52W Range1.78 - 7.45
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.
NGD - New Gold Inc - Stock Price Chart
TickerNGD [AMEX]
CompanyNew Gold Inc
CountryCanada
IndustryGold
Market Cap1.30BEPS (ttm)-0.09
P/E-EPS this Y60.93%
Forward P/E9.60EPS next Y74.78%
PEG-EPS past 5Y46.46%
P/S1.65EPS next 5Y5.00%
P/B1.65EPS Q/Q-61.29%
Dividend-Sales Q/Q19.54%
Insider Own5.65%Inst Own48.06%
Insider Trans0.00%Inst Trans0.88%
Short Float0.88%EarningsApr 30/a
Analyst Recom2.73Target Price2.04
Avg Volume7.36M52W Range0.86 - 1.94
Today 11:15AM New Gold (NGD) Q1 2024 Earnings Call Transcript (Motley Fool) +8.62%
Apr-30-24 05:39PM New Gold: Q1 Earnings Snapshot (Associated Press Finance)
05:15PM NEW GOLD REPORTS FIRST QUARTER 2024 RESULTS (PR Newswire)
Apr-12-24 09:40AM Are Investors Undervaluing New Gold (NGD) Right Now? (Zacks)
Apr-03-24 06:30AM NEW GOLD PROVIDES NOTICE OF RELEASE OF FIRST QUARTER 2024 RESULTS AND CONFERENCE CALL (PR Newswire) +5.26%
Mar-25-24 05:00PM NEW GOLD APPOINTS RICHARD O'BRIEN TO THE BOARD OF DIRECTORS (PR Newswire)
Mar-08-24 12:11PM Why AngloGold Ashanti, Iamgold, and New Gold Are Soaring This Week (Motley Fool)
Feb-15-24 11:02AM New Gold Inc. (AMEX:NGD) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-14-24 11:30AM New Gold (NGD) Q4 2023 Earnings Call Transcript (Motley Fool) -5.00%
Feb-13-24 06:19PM New Gold: Q4 Earnings Snapshot (Associated Press Finance)
New Gold, Inc. is a gold mining company, which engages in the operation, development, and exploration of mineral properties. Its portfolio includes Rainy RIver, New Afton, and Cerro San Pedro. The company was founded on January 31, 1980 and is headquartered in Toronto, Canada.
18910111213141516171820